Class Action Alert: Cerevel Therapeutics Holdings, Inc. Faces Shareholder Lawsuit Over Stock Offering Misconduct

Class Action Alert: Cerevel Therapeutics Holdings, Inc.

On May 8, 2025, The Gross Law Firm announced the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). This legal action pertains to shareholders who purchased shares of Cerevel between October 11, 2023, and August 1, 2024. The firm urges those affected to make contact regarding their eligibility to be appointed as lead plaintiffs.

Key Details of the Case

According to the lawsuit, Cerevel's October 16, 2023 secondary stock offering was fraught with issues. The complaint states that the documents related to this offering failed to disclose crucial information concerning AbbVie's intent to acquire Cerevel at a significantly higher price than the $22.81 per share Offering price. This lack of transparency allegedly caused a temporary artificial deflation of Cerevel's stock prices until the merger was publicly announced.

Further allegations suggest that Bain Capital Investors, LLC, which is a controlling shareholder of Cerevel, purchased shares during this period while possessing insider knowledge about AbbVie's acquisition interest. When AbbVie ultimately declared its intention to buy Cerevel for $45 per share on December 6, 2023, Bain reportedly reaped substantial profits, exceeding $120 million, based on their earlier purchases at the lowered Offering price.

Additionally, the complaint asserts that misleading information was present in Cerevel's Proxy statement dated January 18, 2024, which further obscured the timeline and nature of AbbVie's interest in the company.

Important Dates for Shareholders

The deadline for those wishing to join this class action is June 3, 2025. Shareholders who meet the criteria described are encouraged to register their claims to receive updates on the case's progress through a monitoring software provided by The Gross Law Firm. However, registration to be a lead plaintiff is not mandatory to recover potential losses.

Why Choose The Gross Law Firm?

Recognized across the nation, The Gross Law Firm dedicates itself to protecting the rights of investors impacted by deceptive practices and corporate misconduct. Their mission extends to pursuing justice for investors affected by misleading or false statements, helping to uphold corporate accountability.

If you are a shareholder who sold or held shares of Cerevel during the specified period, this is a critical opportunity to register your claims and potentially reclaim your losses.